Overview
Value-Based Care (VBC) describes a spectrum of payment arrangements that tie some portion of provider reimbursement to measured outcomes, quality performance, and cost efficiency, in contrast to fee-for-service where payment is tied to service volume. The term is a payment-model category, not a single arrangement — it covers upside-only shared-savings programs at the low-risk end, full capitation and global-risk contracts at the high-risk end, and dozens of specific program designs in between.
The spectrum of VBC arrangements is usefully organized by the degree of provider risk. Pay-for-performance programs, such as Medicare's Merit-based Incentive Payment System (MIPS), adjust fee-for-service payments up or down based on quality and cost performance measures but retain the underlying service-based payment. Upside-only shared savings, such as the original Medicare Shared Savings Program (MSSP) Track 1, pay providers a share of savings relative to a benchmark if they hit quality targets but do not penalize over-spending. Two-sided risk programs, such as MSSP ENHANCED and the former Pioneer ACO Model, expose providers to both shared savings and shared losses. Bundled-payment programs — Bundled Payments for Care Improvement Advanced (BPCI-A), Comprehensive Care for Joint Replacement (CJR) — pay a target price for a defined episode of care, with providers absorbing overruns and keeping savings. Capitation and global-risk arrangements, common in Medicare Advantage and some commercial markets, pay a fixed per-member-per-month amount regardless of services rendered.
The operational implications for revenue cycle management are significant. Under fee-for-service, revenue cycle optimization is primarily about claim submission, coding, and denial management — classic RCM. Under risk arrangements, revenue cycle must also track attribution (which members are attributed to the provider), quality measure performance (which drives shared-savings payouts or MIPS adjustments), total cost of care (which determines risk performance), and the timing of settlement payments (often 18–24 months after the performance year). Many VBC programs settle retrospectively — the performance year ends, data runs out, quality scores are calculated, and settlement follows — which creates a multi-year accounts-receivable profile very different from traditional fee-for-service.
CMS has committed to moving all traditional Medicare beneficiaries into accountable-care relationships by 2030, a stated goal of the CMS Innovation Center. Commercial payer adoption varies by market, with Medicare Advantage and some large-employer programs running more heavily on risk-based arrangements than traditional commercial. For providers entering VBC, the practical questions are (1) which programs fit the patient panel, (2) what infrastructure is needed to manage total cost of care — including care management, data integration, and analytics — and (3) how to evolve RCM processes to handle both fee-for-service and risk-based revenue streams simultaneously.
The evidence on VBC impact is mixed. Shared-savings programs have generated modest savings in aggregate but with wide variance across participants. Bundled payments have produced more consistent savings in surgical episodes. Full-risk Medicare Advantage arrangements have demonstrated the strongest outcomes and cost reductions among established programs. Critics note that many VBC programs reward organizations that would have performed well regardless, that quality measures are imperfect proxies for outcomes, and that administrative burden has not decreased. Supporters argue that the directional pressure on total cost of care is essential and that model design is improving.
Industry benchmark
CMS Innovation Center has stated a goal of all traditional Medicare beneficiaries in accountable-care relationships by 2030. Medicare Shared Savings Program, ACO REACH, and MIPS are the largest federal VBC programs. HHS and CMS publish annual evaluation reports on each model's savings and quality performance.
Worked example
A primary-care group joins an MSSP ACO with 12,000 attributed Medicare beneficiaries. The benchmark total cost of care is $10,800 per beneficiary per year. Actual spending comes in at $10,400 per beneficiary. The ACO achieves its minimum savings rate and hits quality thresholds, earning a shared-savings payment of roughly 50% of the $4.8M in savings — approximately $2.4M — distributed to participating providers 12–18 months after year-end settlement.
Frequently asked questions — Value-Based Care
How is value-based care different from fee-for-service?
Fee-for-service pays for the volume and type of services delivered. Value-based care ties some portion of payment to measured outcomes, quality, and total cost of care. Most US providers today operate under a mix of both, with fee-for-service still dominant in aggregate revenue but VBC growing under federal and commercial programs.
What programs fall under value-based care?
Medicare MIPS (pay-for-performance on fee-for-service), the Medicare Shared Savings Program and ACO REACH (shared-savings and risk-based ACO models), bundled-payment programs like BPCI-A and CJR, Medicare Advantage capitated contracts, and a growing set of commercial risk-sharing arrangements. State Medicaid VBC programs vary by state.
What infrastructure does VBC require?
Attribution tracking (which patients count toward the contract), quality-measure capture and reporting, total-cost-of-care analytics, care management to reduce avoidable utilization, and settlement-payment accounting. Providers entering VBC typically add data integration and analytics capabilities that fee-for-service operations do not require.
How long until VBC contracts pay out?
Many VBC programs settle retrospectively — the performance year ends, claims data runs out, quality scores are calculated, and settlement payments arrive 12–24 months after the performance year. This creates a long accounts-receivable tail that requires separate tracking from traditional fee-for-service collections.
Disclaimer
This glossary entry is operational reference for revenue-cycle and medical-billing professionals. It is not legal, clinical, or contractual advice. Industry benchmarks cite named public sources where available; always verify against the current guidance from the authority body before relying on a number in a contract, policy, or compliance filing.